Business Description
Revelation Biosciences Inc
NAICS : 541715
SIC : 2834
ISIN : US76135L5075
Share Class Description:
REVB: Ordinary SharesDescription
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.4 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 66.59 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.69 | |||||
| 9-Day RSI | 39.95 | |||||
| 14-Day RSI | 42.02 | |||||
| 6-1 Month Momentum % | -50.47 | |||||
| 12-1 Month Momentum % | -96.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.64 | |||||
| Cash Ratio | 1.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -166.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -269.81 | |||||
| ROA % | -128.99 | |||||
| ROIC % | -393.29 | |||||
| ROC (Joel Greenblatt) % | -11676.23 | |||||
| ROCE % | -148.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.22 | |||||
| Price-to-Tangible-Book | 1.23 | |||||
| EV-to-EBIT | -1.11 | |||||
| EV-to-EBITDA | -1.11 | |||||
| EV-to-FCF | -0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.27 | |||||
| Price-to-Net-Cash | 1.31 | |||||
| Earnings Yield (Greenblatt) % | -90.09 | |||||
| FCF Yield % | -509.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:REVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Revelation Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -18.58 | ||
| Beta | 0 | ||
| Volatility % | 58.97 | ||
| 14-Day RSI | 42.02 | ||
| 14-Day ATR ($) | 0.056792 | ||
| 20-Day SMA ($) | 0.82569 | ||
| 12-1 Month Momentum % | -96.21 | ||
| 52-Week Range ($) | 0.702 - 25.26 | ||
| Shares Outstanding (Mil) | 4.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Revelation Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Revelation Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Revelation Biosciences Inc Frequently Asked Questions
What is Revelation Biosciences Inc(REVB)'s stock price today?
The current price of REVB is $0.76. The 52 week high of REVB is $25.26 and 52 week low is $0.70.
When is next earnings date of Revelation Biosciences Inc(REVB)?
The next earnings date of Revelation Biosciences Inc(REVB) is .
Does Revelation Biosciences Inc(REVB) pay dividends? If so, how much?
Revelation Biosciences Inc(REVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers